A University of Exeter funding scheme designed to combat the global challenge of fungal antimicrobial resistance (fAMR) has announced a new call for applications.
Merck’s MilliporeSigma agrees to acquire Mirus Bio for $600m
MilliporeSigma operators monitoring viral vector production in a bioreactor in its Carlsbad, California manufacturing facility. Credit: Business Wire/Merck KGaA, Darmstadt, Germany and/or its affiliates. Merck